News: CVS Caremark Corp (CVS)
59.20USD
24 May 2013
$0.87 (+1.49%)
$58.33
$58.29
$59.35
$57.96
4,244,909
5,684,857
$60.66
$43.30
Wed, May 1 2013
CVS Caremark profit rises, helped by generics, flu season
- CVS Caremark Corp posted a higher than expected first-quarter profit on Wednesday, helped by more profitable generic drugs on the market and a severe cold and flu season that boosted sales at its drugstores.
UPDATE 2-CVS Caremark profit rises, helped by generics, flu season
* CEO still confident can keep 60 pct of business won from Walgreen fight
BRIEF-CVS Caremark CEO says competiton for PBM contracts currently "competitive, yet rational"
May 1 - CVS Caremark Corp : * CEO says competiton for pbm contracts currently "competitive, yet rational" * CFO sees FY net revenue growth 1.75-3 percent * CFO sees FY net revenue growth 1.75-2.75 percent in pbm unit * CFO sees FY net revenue growth 2.25 percent-3.5 percent in retail pharmacy
BRIEF-CVS still "very confident" can keep 60 pct of scripts from Walgreen-Express Scripts spat
May 1 - CVS Caremark Corp : * Still "very confident" can keep at least 60 percent of scripts in 2013 gained
CVS Caremark posts higher profit, helped by flu season, generics
NEW YORK, May 1 - CVS Caremark Corp posted higher quarterly profit on Wednesday, as a more severe cold and flu season boosted sales and more new generic drugs hit the market.
CVS Caremark gets contract to serve 1.1 million CareFirst members
- CVS Caremark Corp is set to provide pharmacy benefit and other services for 1.1 million CareFirst BlueCross BlueShield members starting next year, a deal that could represent about $1 billion in annual spending on medications and boost CVS' profit by a penny per share, an industry analyst said.
CVS Caremark gets contract to serve 1.1 mln CareFirst members
April 30 - CVS Caremark Corp is set to provide pharmacy benefit and other services for 1.1 million CareFirst BlueCross BlueShield members starting next year, a deal that could represent about $1 billion in annual spending on medications and boost CVS' profit by a penny per share, an industry analyst said.
UPDATE 3-CVS buys Brazil's Onofre in first international deal
* 8th biggest Brazilian chain boasts best efficiency ratios
UPDATE 2-CVS Caremark profit up, buys Brazil's Onofre chain
* Profit of $1.14/share excluding items vs Street view $1.10
BRIEF-CVS Caremark says U.S. postal service decision to end Saturday delivery should have minimal impact
CHICAGO, Feb 6 - CVS Caremark Corp : * Says U.S. postal service decision to end Saturday delivery should have
- Cramer's Lightning Round - Oracle Is A Hard-Fought Name (5/22/13)
- CVS Caremark's Management Presents at Barclays Americas Select Franchise Conference - Special Call Transcript
- Bullish On Wal-Mart: Revisiting Long-Term Thesis
- Are Streaks And Current Yields The Best Metrics For Dividend Growth Investors?
- Attractively Valued Stocks To Consider Today
- Aetna Appears Undervalued
Press Releases
- CVS Caremark Supporting Tornado Relief Efforts in Oklahoma and Texas
- CVS/pharmacy® Reminds Patients with Diabetes about the Importance of Regular Testing to Help Manage Their Disease
- CVS Caremark Donates Over $750,000 to The One Fund Boston
- CVS Caremark Research Finds Women and Non-White Patients More Likely to be Non-Adherent to Medications
- CVS Caremark to Present at the Barclays Capital Americas Select Franchise Conference
- CVS/pharmacy® Launches New Exclusive Line of Household Essentials, Total Home™, Now Available Nationwide
- CVS Caremark Publishes New Corporate Social Responsibility Report
- Don't Forget Mom this Mother's Day with Thoughtful Last-Minute Gifts and Cards from CVS/pharmacy®
- CVS Caremark Reports Strong First Quarter Results
- CVS Caremark to Participate in White House Effort to Hire Veterans and Military Spouses
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
